Nothing Special   »   [go: up one dir, main page]

MX2024010624A - Metodo para producir medetomidina y sus derivados. - Google Patents

Metodo para producir medetomidina y sus derivados.

Info

Publication number
MX2024010624A
MX2024010624A MX2024010624A MX2024010624A MX2024010624A MX 2024010624 A MX2024010624 A MX 2024010624A MX 2024010624 A MX2024010624 A MX 2024010624A MX 2024010624 A MX2024010624 A MX 2024010624A MX 2024010624 A MX2024010624 A MX 2024010624A
Authority
MX
Mexico
Prior art keywords
medetomidine
derivatives
producing
formula
field
Prior art date
Application number
MX2024010624A
Other languages
English (en)
Inventor
Dmitrii Sergeevich Orehov
Boris Viktorovich Violin
Original Assignee
Obshestvo S Ogranichennoi Otvetstvennostiu Vik Zdorove Zhivotnykh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2022107497A external-priority patent/RU2791397C1/ru
Application filed by Obshestvo S Ogranichennoi Otvetstvennostiu Vik Zdorove Zhivotnykh filed Critical Obshestvo S Ogranichennoi Otvetstvennostiu Vik Zdorove Zhivotnykh
Publication of MX2024010624A publication Critical patent/MX2024010624A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C07C49/233—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B59/00—Hull protection specially adapted for vessels; Cleaning devices specially adapted for vessels
    • B63B59/04—Preventing hull fouling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B59/00—Hull protection specially adapted for vessels; Cleaning devices specially adapted for vessels
    • B63B59/04—Preventing hull fouling
    • B63B59/045—Preventing hull fouling by wrapping the submerged hull or part of the hull with an impermeable sheet

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Engineering & Computer Science (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • Ocean & Marine Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere al campo de la química farmacéutica y describe métodos para obtener medetomidina de la fórmula 2. (ver Fórmula) y sus derivados de la fórmula 3 y la fórmula 24 (ver Fórmula) a partir del compuesto de inicio 5 (ver Fórmula).
MX2024010624A 2022-03-22 2022-10-28 Metodo para producir medetomidina y sus derivados. MX2024010624A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2022107497A RU2791397C1 (ru) 2022-03-22 Способ получения медетомидина и производных
PCT/RU2022/050341 WO2023182903A1 (ru) 2022-03-22 2022-10-28 Способ получения медетомидина и его производных

Publications (1)

Publication Number Publication Date
MX2024010624A true MX2024010624A (es) 2024-09-05

Family

ID=88101949

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024010624A MX2024010624A (es) 2022-03-22 2022-10-28 Metodo para producir medetomidina y sus derivados.

Country Status (4)

Country Link
KR (1) KR20240148807A (es)
CN (1) CN117295718A (es)
MX (1) MX2024010624A (es)
WO (1) WO2023182903A1 (es)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US5599986A (en) 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
GB2453982B (en) 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
CN102753532B (zh) 2009-12-09 2015-05-13 I-技术有限公司 美托咪定的制备方法
PL2734508T3 (pl) 2011-07-22 2018-08-31 Cambrex Karlskoga Ab Nowe sposoby wytwarzania 4-podstawionych imidazoli
WO2012172120A2 (en) 2012-05-08 2012-12-20 Lonza Ltd 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume
WO2012172122A2 (en) 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal
GB201501593D0 (en) * 2015-01-30 2015-03-18 Cambrex Karlskoga Ab New compounds and processes
CN106588777A (zh) 2015-10-16 2017-04-26 江苏开元医药化工有限公司 一种盐酸右美托咪定的工业化制备方法
CN105254567B (zh) 2015-11-18 2018-01-19 扬子江药业集团有限公司 一种制备盐酸右美托咪定关键中间体的方法
CN105884691B (zh) 2016-06-02 2017-08-25 江苏恒瑞医药股份有限公司 一种制备右美托咪定及其中间体的方法
CN106083724B (zh) 2016-08-02 2018-06-26 江苏恒瑞医药股份有限公司 一种右美托咪定的制备方法
CN106518812A (zh) 2016-10-25 2017-03-22 湖南大学 一种美托咪定及其中间体的制备方法
CN106749027B (zh) 2016-11-21 2019-03-22 石药银湖制药有限公司 一种盐酸右美托咪定中间体的合成工艺
CN107857731A (zh) 2017-11-03 2018-03-30 江苏正大清江制药有限公司 一种制备盐酸右美托咪定的工艺方法
CN108147999B (zh) 2017-12-29 2019-09-20 上海博志研新药物技术有限公司 盐酸右美托咪定及其中间体的制备方法
CN109608400A (zh) 2018-12-31 2019-04-12 辰欣药业股份有限公司 一种盐酸右美托咪定的合成方法
KR102253950B1 (ko) 2019-07-24 2021-05-20 (주)에니켐텍 신규한 메데토미딘 제조방법
WO2021089878A1 (en) 2019-11-08 2021-05-14 Norchim Method for preparing dexmedetomidine
CN111217756B (zh) 2019-12-11 2022-03-11 南京亿华药业有限公司 一种盐酸右美托咪定的制备方法
CN112979552B (zh) 2019-12-16 2024-08-13 广安凯特制药有限公司 一种高纯度盐酸右美托咪定的制备方法
CN111253316A (zh) 2020-03-31 2020-06-09 陕西博森生物制药股份集团有限公司 一种盐酸右美托咪定的制备方法

Also Published As

Publication number Publication date
CN117295718A (zh) 2023-12-26
KR20240148807A (ko) 2024-10-11
WO2023182903A1 (ru) 2023-09-28

Similar Documents

Publication Publication Date Title
CR20220354A (es) Inhibidores de egfr
EA202091466A1 (ru) Синтез сокристалла 1:1:1 1-циано-2-(4-циклопропилбензил)-4-(-d-глюкопираноз-1-ил)бензола, l-пролина и воды
SG11201906688VA (en) Novel ester compounds, method for the production thereof and use thereof
MX2022005229A (es) Un nuevo proceso eficaz para la sintesis de 2-amino-5-cloro-n,3-di metilbenzamida.
WO2021205388A3 (en) An improved process for the preparation of semaglutide side chain
SA520412408B1 (ar) عملية تحضير مركبات ثنائي أريل أوكسي بنزو ديازول غير متجانسة مزدوجة الاستبدال
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
EP4169925A3 (en) Process to make n-substituted tetrahydrothienopyridine derivatives
MX2022002941A (es) Cristal de derivado de 1,3,5-triazina o solvato del mismo y metodo para producir el mismo.
MX2022002017A (es) Metodo para producir derivado de heterociclideno acetamida.
MX2024010624A (es) Metodo para producir medetomidina y sus derivados.
MX2023000970A (es) Metodo de preparacion de aminofuranos.
MX2022001167A (es) Metodo para el tratamiento de una composicion que comprende vainillina natural.
MX2021007511A (es) Procedimiento para la preparacion de anilinas sustituidas.
MX2022006142A (es) Proceso para la sintesis de (3-cloro-2-piridil)hidrazina.
EP4289844A3 (en) A process for making palbociclib
MY141776A (en) Method for producing 4-nitroimidazole compound
EP4249491A3 (en) Process for preparing bicyclic enolether
AR126196A1 (es) Proceso para preparar inhibidores de egfr
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
EA202092445A1 (ru) Способ получения 2-метил-4-(2,6,6-триметил-1-циклогексен-1-ил)-2-бутеналя
MX2023015302A (es) Metodo para producir derivados del acido isoxazolincarboxilico.
MX2023004094A (es) Metodo para la preparacion de carbonilaminofuranos.
MX2024008443A (es) Proceso de preparacion de derivados de octahidro-2(1h)-naftalenona .
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung